Tag Archive
Nanotech used to create pulsing artificial arteries (CIO)
A team of British researchers are set to begin a trial program by planting nanotechnology-based artificial arteries into humans. (read on…) Related items DNA nanotechnology breakthrough offers promising applications in medicine (w/ Video) (PhysOrg) Buff Briefs | CU hosts nanotech symposium in April (Boulder Weekly) Governor Rendell: State Investments Lead Nanotech Company to Expand in Centre County (PR Newswire... »
No verdict, just read-backs (The Troy Record)
ALBANY — Jurors in the federal corruption trial of former Senate Majority Leader Joseph L. Bruno deliberated for a second full day on Monday without reaching a verdict and asked to hear the entire testimony from a former Senate staffer about state grants that went to a Troy-based company with ties to one of... »
Bayer’s NEXAVAR approved in over 70 countries for the treatment of liver cancer (News-Medical-Net)
Bayer Inc. announced today that its international trial known as SHARP (Sorafenib HCC Assessment Randomized Protocol), led by Study Manager and Bayer Canada employee Tom Giannaris, has been selected as the winner in the ‘Best International Trial’ category for the Global Clinical Practice Journal Awards. (read here…) Related items World’s first Cs-131 implant for colorectal cancer performed... »
MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients (News-Medical-Net)
MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma. (read the story…) Related items MagForce Nanotechnologies AG reaches primary study endpoint in pivotal glioblastoma study (Business Wire via Yahoo! Finance) Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical... »
MagForce Nanotechnologies AG reaches primary study endpoint in pivotal glioblastoma study (Business Wire via Yahoo! Finance)
BERLIN—-MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma. (read the story…) Related items MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients (News-Medical-Net) MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance) Gold nanoparticles for cancer treatment... »
